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GUEST EDITORIAL
Anaemia (part 2)
According to the World Health Organization, anaemia is defined as 
‘a condition in which the number of red blood cells or their oxygen-
carrying capacity is insufficient to meet physiologic needs’.[1]
The number of anaemic people worldwide is estimated to be a 
staggering 2 billion, of whom ~50% have iron-deficiency anaemia 
(IDA).[1] Of major concern are the more serious consequences of IDA 
on the cognitive and physical development of children and the work 
productivity of adults. Furthermore, the increased risk of maternal, 
child and postoperative morbidity due to severe anaemia has been 
well documented.
Given the vastness of the subject, a systematic approach to 
diagnosis is crucial. In this series, anaemia has been divided into two 
causative categories, i.e.: 
• Decreased bone marrow production or output of red cells, dis-
cussed in the previous issue of this CME series.[2]
• Peripheral loss (bleeding, sequestration or haemolysis) of red cells, 
which is the subject of discussion in the current issue.
Of the causes of anaemia due to peripheral loss of red cells, haemo-
lytic anaemia represents the largest group. Understanding the patho-
physiology of intra- and extravascular haemolysis is of paramount 
importance, as the clinical presentation and management of the two 
varieties differ in many respects.
Globally, the prevalence of inherited haemolytic anaemias (inclu-
ding thalassaemia, glucose-6-phosphate dehydrogenase deficiency, 
globin chain variants, e.g. sickle cell disease (SCD)), is highest in 
areas endemic to malaria. A striking overlap between the geo-
graphical distribution of inherited haemolytic anaemias and malaria 
endemi city led researchers to explore the effect of this co-existence. 
In vitro studies have demonstrated decreased parasite survival in 
the red cells of affected individuals (mostly heterozygous). These 
experiments led investigators to conclude that selective survival from 
partial protection against malaria has ensured persistence of these 
conditions. SCD serves as a classic example to illustrate the point. In 
some parts of Africa, the childhood mortality for the homozygous 
state (SS) exceeds 60%. As a consequence of such a severe clinical 
entity, the sickle gene is expected to dwindle to extinction as a result 
of its progressive dilution over subsequent generations. However, the 
sickle gene is anything but extinct, and is prevalent in polymorphic 
frequencies in some geographical regions. The primary reason for 
this observation is attributed to partial protection enjoyed by the 
heterozygous state against malaria, and it is this selective survival 
advantage that has led to persistence of the sickle gene. Various mech-
anisms for protection against malaria have been proposed, of which 
two are widely accepted: (i) K+ is an absolute requirement for parasite 
surival. Sickle cells have decreased intracellular K+ (from K+ loss due 
to red cell membrane damage), thus compromising parasite survival; 
(ii) the intracellular pH in parasite-infected red cells drops, which trig-
gers the sickling process. The parasitised sickle cells are then selectively 
removed by splenic macrophages.
Transformation of the South African (SA) political landscape 
after the first democratic election in 1994 occasioned relaxation of 
SA immigration laws. This led to an influx of visitors for business, 
leisure and employment purposes from various parts of the world. 
Consequently, healthcare workers are now exposed to inherited 
haemolytic conditions previously not highly prevalent in SA.
Physiological states of anaemia, 
e.g. pregnancy, are not included for 
discussion in this CME series.
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